Education
About Us
Working with TipRanks
Follow Us
Wellnex Life Ltd (AU:WNX)
ASX:WNX
WNX Stock Chart & Stats
AU$0.09
AU$0.01(1.47%)
At close: 4:00 PM EST
AU$0.09
AU$0.01(1.47%)
Day’s Range― - ―
52-Week RangeAU$0.08 - AU$0.61
Previous CloseN/A
Volume2.27K
Average Volume (3M)51.95K
Market Cap
AU$5.39M
Enterprise ValueAU$14.45M
Total Cash (Recent Filing)AU$975.00K
Total Debt (Recent Filing)AU$10.03M
Price to Earnings (P/E)―
Beta1.68
Next Earnings
Aug 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding69,955,475
10 Day Avg. Volume31,968
30 Day Avg. Volume51,946
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.69
Price to Sales (P/S)0.33
P/FCF Ratio-11.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Focused OTC Topical Product PortfolioA focused product strategy in OTC pain relief and topical delivery formats supports durable consumer demand and repeat purchases. This specialization aids product differentiation, enables targeted R&D and marketing, and helps build brand equity in a stable, defensive consumer-health category over months.
Established Pharmacy And Retail DistributionDirect access to pharmacy and retail channels provides a durable route-to-market and repeat demand for OTC goods. Long-term relationships and shelf presence in these channels support steady revenue streams, merchandising advantages, and lower customer acquisition costs versus nascent direct channels.
Manageable Leverage And Stable Asset BaseA moderate debt-to-equity ratio gives the company financial flexibility to fund working capital and invest in distribution or product development without excessive interest burden. A stable asset base supports resilience during revenue volatility and preserves capacity for strategic initiatives.
Bears Say
Sustained Operating LossesPersistent negative EBIT and net margins erode intrinsic profitability and limit the company's ability to self-fund growth or marketing investment. Over a multi-month horizon this reduces strategic optionality, pressures stakeholder confidence, and may necessitate dilutive or costly external financing.
Negative Operating And Free Cash FlowNegative operating and free cash flows indicate the business is burning cash to run current operations. Structurally weak cash generation constrains inventory, promotional spend and distribution support, increases reliance on external funding, and heightens vulnerability to supply or demand shocks.
Negative Return On EquityA negative ROE shows capital is not creating shareholder value and signals inefficient use of equity. Over the medium term this raises cost of capital, deters long-term investors and partners, and requires meaningful operational improvements to restore returns and support sustainable growth.
Wellnex Life Ltd News
WNX FAQ
What was Wellnex Life Ltd’s price range in the past 12 months?
Wellnex Life Ltd lowest share price was AU$0.08 and its highest was AU$0.60 in the past 12 months.
What is Wellnex Life Ltd’s market cap?
Wellnex Life Ltd’s market cap is AU$5.39M.
When is Wellnex Life Ltd’s upcoming earnings report date?
Wellnex Life Ltd’s upcoming earnings report date is Aug 28, 2026 which is in 163 days.
How were Wellnex Life Ltd’s earnings last quarter?
Wellnex Life Ltd released its earnings results on Feb 26, 2026. The company reported -AU$0.026 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.026.
Is Wellnex Life Ltd overvalued?
According to Wall Street analysts Wellnex Life Ltd’s price is currently Overvalued.
Does Wellnex Life Ltd pay dividends?
Wellnex Life Ltd does not currently pay dividends.
What is Wellnex Life Ltd’s EPS estimate?
Wellnex Life Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Wellnex Life Ltd have?
Wellnex Life Ltd has 69,955,475 shares outstanding.
What happened to Wellnex Life Ltd’s price movement after its last earnings report?
Wellnex Life Ltd reported an EPS of -AU$0.026 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Wellnex Life Ltd?
Currently, no hedge funds are holding shares in AU:WNX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Wellnex Life Ltd Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-62.14%
12-Months-Change
Fundamentals
Return on Equity
-92.72%
Trailing 12-Months
Asset Growth
-17.21%
Trailing 12-Months
Company Description
Wellnex Life Ltd
Wellnex Life Limited develops health and wellness solutions in Australia. The company provides organic baby skincare products under the Little Innoscents; nutritional support products under the Performance Inspired; iron gummies under The Iron Company; organic milk under the Uganic; natural energy products under the Wakey Wakey; smooth textured capsules under the Liquigesic; and garlic products under the SupaGarlic brands. It also offers bin cleanser solutions under the Bin Buddy; medical products under the Bird Healthcare; gel plasters for treating blisters, corns, cracked heels, and cold sores under the Compeed; oral emergency contraception pills under the EllaOne; skincare solutions under the Koéna; canned meats under the Plumrose; snacks under the Simply7; skincare products under the edited; natural herbal skincare products under the naked klay; and natural essential oil blends under the Planet Remedy brands. In addition, the company provides contract manufacturing services. Wellnex Life Limited has a collaboration with Onelife Botanicals for the manufacture, distribution, and sales of cannabis and hemp-based products. The company was formerly known as Wattle Health Australia Limited and changed its name to Wellnex Life Limited in June 2021. Wellnex Life Limited was incorporated in 2011 and is headquartered in Melbourne, Australia.
Technical Analysis
EVE Health Group Limited
―
Nuchev Pty Ltd
―
―
Holista Colltech Limited
―
Nutritional Growth Solutions Ltd.
―
Options Prices
Currently, No data available
---